News and Press Releases
Lyphe and Gro-Vida Announce Partnership to Enhance Medical Cannabis Access
13 June 2024 -- London, UK -- Lyphe Clinic is thrilled to announce its partnership with Gro-Vida, a licensed medical cannabis cultivar. Lyphe Clinic is a leading medical cannabis clinic based...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024
ACG Partners with EY-Parthenon to drive sustainable practices and achieve net zero goals
12 June 2024 -- Mumbai, India -- ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, has announced a strategic partnership with EY-Parthenon, one of the...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: June 13, 2024
IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
Bold initiative to boost the capacity of research sites enters Beta testing and piloting 12 June 2024 -- North Carolina, US -- IQVIA today announced the launch of One Home...
Category: Clinical Trials, Drug Discovery, Other
Posted: June 12, 2024
Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
12 June 2024 -- Delaware, US -- Mage Biologics announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 12, 2024
CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT
CluePoints is a cloud-based software platform for Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials, designed to enable safer and more efficient processes and improving data integrity...
Category: Biotechnology, Clinical Trials
Posted: June 12, 2024
SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases
12 June 2024 -- Munich, Germany -- SciRhom GmbH, a biopharmaceutical company pioneering the development of first-in-class therapeutic antibodies, announced today the approval of a clinical trial application (CTA) by...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 12, 2024
Enterprise Therapeutics publishes preclinical profile of ETD001, a novel inhaled ENaC blocker
Low doses of ETD001 demonstrate exceptionally long duration of action in sheep model of airway mucus clearance Report in Journal of Cystic Fibrosis discloses best-in-class profile of ETD001 ETD001 scheduled...
Category: Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Pharmaceutical
Posted: June 12, 2024
Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK
Unlock the future of cell analysis with Celledonia
10 June 2024 – Meet Celledonia, the new and revolutionary benchtop cell analyser that will inform and expedite your bioprocesses and turn your data into actionable insights. TechBio company Cytomos...
Category: Biotechnology, Drug Discovery
Posted: June 12, 2024
Middle Wing Building University of Edinburgh Easter Bush Campus Roslin EH25 9RG Scotland
CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’
CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials 11 June 2024 -- Pennsylvania, US -- CluePoints, provider of leading statistical and AI-driven...
Category: Clinical Trials, Other, Pharmaceutical
Posted: June 11, 2024
Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
11 June 2024 -- Lund, Sweden -- Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it selected Exothera, a leading...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: June 11, 2024
Amgen announces positive results for phase 3 registrational trial evaluating Inebilizumab for treatment of immunoglobulin G4-related diseases (IgG4-RD)
Data shows a statistically significant 87% reduction in IgG4-RD flares, with primary and all key secondary endpoints met First randomised, placebo-controlled trial to demonstrate benefit in IgG4-RD 5 June 2024...
Category: Biotechnology, Drug Discovery
Posted: June 11, 2024
Launch of UK’s first robotic genomic testing facility for cancer patients
World-leading cancer hospital pioneers automation to increase patient access to wider range of state-of-the-art tests 11 June 2024 – London, UK – For the first time in the UK, robotic...
Category: Biotechnology, Drug Discovery
Posted: June 11, 2024
IFF to unveil breakthrough alginate technologies for biomedical innovation at WBC and TERMIS
27 May 2024 – New York, US – IFF (NYSE: IFF), a global leader in food and beverage, home and personal care and health will unveil groundbreaking study results at...
Category: Biotechnology, Drug Discovery
Posted: June 11, 2024
Bespak reaches key milestone in the expansion of its manufacturing capacity, with further expansion plans underway to meet global customer demand for climate friendly inhalers
11 June 2024 – Holmes Chapel, UK – Bespak, a leading contract development and manufacturing organisation (CDMO) focused on orally inhaled and nasal drug-device combination products, is today announcing progress...
Category: Manufacturing and Packing
Posted: June 11, 2024
Keystone Folding Box Co introduces new child-resistant wallet card for blisters
Company’s Push-Pak provides simple push-through openingfeature, enabling compact blister design and reduced material usage. 4 June 2024 – Newark, NJ, US – Keystone Folding Box Co., a designer and manufacturer...
Category: Drug Delivery, Manufacturing and Packing
Posted: June 11, 2024
